The demarcation between drugs and medical devices

Latest Perspectives

• January 31

  2019

  China's SAMR Fines Hunan Er-Kang and Henan Jiushi CNY 10 million for Unfair Pricing of Chlorpheniramine API

  9 Minute Read

• January 24

  2019

  Europe—New Regulation (EU) 2019/5 Extends Financial Penalties to Entities Beyond the Marketing Authorization Holder and Updates the Legal Framework for Medicinal Products for Human Use

  10 Minute Read

• December 10

  2018

  Europe—General Court Confirms Obligation to Prove Significant Benefit Over All Authorized Medicinal Products, Including Those Authorized After the Submission of the Marketing Authorization Application for the Future (Orphan) Product

  14 Minute Read